Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Litigation in general

My interpretation only and corrections welcome

We know from Moore that he has presented TPL with a settlement agreement but has not received a response from Leckrone and there is no follow up posted on his blog (as of today)

We know from the recent 10Q that our BoD continues negotiations with TPL and that their intention is to continue their relationship with TPL ....different terms perhaps

We know that April 22 is a big court date for Acer/HTC/Barco motions (infringement and invalidity)

In case you don't know and based on pacer info received from Wolf, I will try to summarize what Barco is doing (re: invalidity)

Barco had filed a motion for leave to amend invalidity contentions

TPL said that Barco was not diligent in amending its invaldity contentions and that Moore's testimony is irrelevant

Barco's response to arguments raised by TPL:

Barco has been diligent, Barco's motion to amend is based on newly discovered evidence. There is no way for Barco to discover the info on which it relies to amend, prior to Moore's deposition

Barco basically says that other evidence, such as an inventor's testimony can be used to determine if the requirements of enablement & written description are met

April 22 9:05 Barco's reply brief on its motion for leave to amend invalidity contentions

Share
New Message
Please login to post a reply